已收盤 11-20 16:00:00 美东时间
-0.840
-5.93%
11月21日,Sarepta Therapeutics(SRPT)收跌5.93%,报13.33美元,成交额3061.56万美元,市值14.29亿美元。 行情数据...
11-21 06:33
今日重点评级关注:摩根大通:维持Biohaven"超配"评级,目标价从14美元升至35美元;Craig-Hallum:维持红罗宾"买入"评级,目标价从14.5美元升至15.5美元
11-20 08:33
JP Morgan analyst Anupam Rama maintains Sarepta Therapeutics (NASDAQ:SRPT) with a Neutral and raises the price target from $20 to $22.
11-20 03:08
11月14日,Sarepta Therapeutics(SRPT)收涨0.37%,报16.07美元,成交额2124.5万美元,市值17.23亿美元。 行情数据...
11-14 06:30
Sarepta Therapeutics Inc. ($SRPT) announced an update on their ongoing clinical...
11-11 00:30
今日重点评级关注:瑞银:维持Liberty Media"中性"评级,目标价从110美元升至1116美元;杰富瑞:维持伊诺维奥制药"买入"评级,目标价从3美元升至8美元
11-09 14:00
11月7日,Sarepta Therapeutics(SRPT)收涨1.42%,报17.82美元,成交额4639.54万美元,市值18.82亿美元。 行情数据...
11-07 06:26
RBC Capital analyst Brian Abrahams maintains Sarepta Therapeutics (NASDAQ:SRPT) with a Sector Perform and raises the price target from $17 to $18.
11-07 03:00
最新财报显示,Sarepta Therapeutics 2026财年第3季度实现: 营业收入:3.81亿美元 同比:下降4.51% 每股收益:-0.27美元 同...
11-07 03:00
Sarepta Therapeutics (NASDAQ:SRPT) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate of $0.06 by 116.67 percent. This is a 200 percent increase over losses of $(0.13) per share from the same period last year. The company reported quarterly sales of $381.400 mil...
11-06 05:24